This means that PD-1 enhancers can be used to suppress uveitis T cells, because B7-H1, which is a ligand for PD-1, is constitutively expressed in ocular tissues such as retina/RPE [19,20] and cornea [34,38]. The gene discussed is PDCD1; the disease is uveitis.